The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Erlotinib monotherapy in the treatment of advanced non-small cell lung carcinoma: A single center experience with 187 patients from 2005-2018.
 
Felipe Matsunaga
No Relationships to Disclose
 
David Pfau
No Relationships to Disclose
 
Kai Laukamp
No Relationships to Disclose
 
Elias Kikano
No Relationships to Disclose
 
Nikhil H. Ramaiya
No Relationships to Disclose
 
Afshin Dowlati
Consulting or Advisory Role - Abbvie/Stemcentrx; ARIAD
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Lilly/ImClone (Inst); MedImmune (Inst); OncoMed (Inst)